Loading...
•
Mar 31, 2022
Treace Q1 2022 Earnings Report
Treace Medical Concepts reported financial results for the first quarter ended March 31, 2022.
Key Takeaways
Treace Medical Concepts reported a strong start to 2022, with revenue increasing by 55% compared to the same period last year. The company is raising its full year 2022 revenue guidance to $128 million to $133 million.
Revenue of $29.0 million, a 55% increase over the same period last year.
Gross margin of 81.0%.
Direct sales channel contributed 63% of sales, up from 44% in the first quarter 2021.
New five-year $150 million loan arrangement secured.
Forward Guidance
Treace is raising its full year 2022 revenue guidance to $128 million to $133 million, which represents approximately 36% to 41% growth over the Company’s 2021 revenue.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...